![]() |
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2018-12-03 Sale |
2018-12-06 5:54 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
1,178 | $90 | $106,020 | 1,947 (Direct) |
View |
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2019-02-07 Option Award |
2019-02-08 5:04 pm |
N/A 2029-02-07 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
83,341 | $81.05 | 83,341 (Direct) |
View |
2019-02-07 Option Award |
2019-02-08 5:04 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
15,423 | $0 | 83,341 (Direct) |
View |
2018-02-05 Option Award |
2018-02-07 5:59 pm |
N/A 2021-03-15 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
12,250 | $0 | 12,250 (Direct) |
View |
2018-02-05 Option Award |
2018-02-07 5:59 pm |
N/A 2020-02-05 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
12,250 | $0 | 12,250 (Direct) |
View |
2017-12-01 Option Award |
2017-12-05 4:24 pm |
N/A 2027-12-01 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
60,000 | $73.6 | 60,000 (Direct) |
View |
2017-12-01 Option Award |
2017-12-05 4:24 pm |
N/A N/A |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT CFO |
12,500 | $0 | 60,000 (Direct) |
View |
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 17 Feb 2019 10:03:43 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |